Video

Dr. Trent on the Role of ctDNA in Soft Tissue Sarcoma

Jonathan C. Trent, MD, PhD, discusses the role of circulating tumor DNA in soft tissue sarcoma. 

Jonathan C. Trent, MD, PhD, professor and associate director for Clinical Research at the Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses the role of circulating tumor DNA (ctDNA) in soft tissue sarcoma. 

ctDNA could ​play an important role in terms of therapy selection following imatinib (Gleevec) resistance, says Trent. 

For example, patients with secondary-resistant, KIT exon 13​–mutant gastrointestinal stromal tumors (GISTs) seem to be sensitive to sunitinib (Sutent), despite being resistant to other TKIs. 

Conversely, patients with KIT exon 17–mutant GIST​s who are resistant to imatinib seem to be resistant to sunitinib but sensitive to other TKIs, Trent concludes. 

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina
Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity
18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
Video

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Apr 8th 2025 - May 14th 2025

online-activity